|
November 3, 2005
Abgenix Reports Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study
October 25, 2005
Abgenix Announces Third Quarter 2005 Financial Results
November 2, 2005
Aspreva Pharmaceuticals Reports Third Quarter 2005 Results
October 6, 2005
Aspreva and Roche conclude Special Protocol Assessment and reach agreement with FDA
October 24, 2005
Cardiome Acquires Artesian Therapeutics
October 19, 2005
Cardiome and Astellas Initiate ACT 4 Study
October 4, 2005
Cardiome Appoints Peter W. Roberts as Director
October 5, 2005
Chromos Enters into License Agreement with BD For T-Cell Expansion Patents
November 2, 2005
Forbes Medi-Tech Initiates US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4
October 27, 2005
Forbes Medi-Tech Completes US$6 Million Private Placement
October 3, 2005 - Forbes Medi-Tech Receives FDA Clearance to Initiate US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4
October 10, 2005
iCELL Therapeutics receives support from the National Research Council’s Industrial Assistance Program for development of Cancer Treatment
October 27, 2005
Inex Pharmaceuticals Receives Positive Court Outcome
October 12, 2005
Inex Pharmaceuticals Hearing Completed
November 7, 2005
Inflazyme Announces Financial Results for the Quarter Ended September 30, 2005; Strengthens Financial Position
October 19, 2005
Inimex Selected to Present at Two San Francisco Venture Financing Conferences
October 25, 2005
OncoGenex Initiates Fourth Phase 2 Clinical Trial of OGX-011 in Cancer
October 12, 2005
OncoGenex Initiates Third of Four Phase 2 Clinical Trials of OGX-011 in Cancer
October 24, 2005
PACGEN Contracts Vancouver-based Syreon Corp for its Phase I/II Clinical Trial of PAC113 Mouthrinse in HIV Seropositive Patients with Oral Candidiasis
October 25, 2005
Perceptronix to Present Lung Cancer Detection Test Clinical Trial Results at International Conference “CHEST 2005"
October 27, 2005
Protox announces $4.0 million Equity Financing
November 1, 2005
TranSenda Names Ruth Martens Scott Advisory Board Member
October 17, 2005
Romel Joins TranSenda as Business Development Executive
Read all BC Biotech Member News
Want to see your company's news in biolinks? Email the Editor. |
